316 related articles for article (PubMed ID: 30905350)
1. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A
Nikolaou A; Kokotou MG; Vasilakaki S; Kokotos G
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):941-956. PubMed ID: 30905350
[TBL] [Abstract][Full Text] [Related]
2. The design and discovery of phospholipase A
Batsika CS; Gerogiannopoulou AD; Mantzourani C; Vasilakaki S; Kokotos G
Expert Opin Drug Discov; 2021 Nov; 16(11):1287-1305. PubMed ID: 34143707
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of phospholipase A
Kokotou MG; Limnios D; Nikolaou A; Psarra A; Kokotos G
Expert Opin Ther Pat; 2017 Feb; 27(2):217-225. PubMed ID: 27718763
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.
Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS
Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
6. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
[TBL] [Abstract][Full Text] [Related]
7. The role of phospholipase A2 in multiple Sclerosis: A systematic review and meta-analysis.
Trotter A; Anstadt E; Clark RB; Nichols F; Dwivedi A; Aung K; Cervantes JL
Mult Scler Relat Disord; 2019 Jan; 27():206-213. PubMed ID: 30412818
[TBL] [Abstract][Full Text] [Related]
8. Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry.
Hsu YH; Dumlao DS; Cao J; Dennis EA
PLoS One; 2013; 8(3):e59267. PubMed ID: 23533611
[TBL] [Abstract][Full Text] [Related]
9. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
10. Membrane Association Allosterically Regulates Phospholipase A
Mouchlis VD; Dennis EA
Acc Chem Res; 2022 Dec; 55(23):3303-3311. PubMed ID: 36315840
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2 structure/function, mechanism, and signaling.
Burke JE; Dennis EA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S237-42. PubMed ID: 19011112
[TBL] [Abstract][Full Text] [Related]
13. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of Xenorhabdus hominickii, an entomopathogenic bacterium, against different types of host insect phospholipase A
Sadekuzzaman M; Kim Y
J Invertebr Pathol; 2017 Oct; 149():97-105. PubMed ID: 28803982
[TBL] [Abstract][Full Text] [Related]
15. The synthetic varespladib molecule is a multi-functional inhibitor for PLA
Salvador GHM; Borges RJ; Lomonte B; Lewin MR; Fontes MRM
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129913. PubMed ID: 33865953
[TBL] [Abstract][Full Text] [Related]
16. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
[TBL] [Abstract][Full Text] [Related]
17. Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.
Lewin M; Samuel S; Merkel J; Bickler P
Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27571102
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
[TBL] [Abstract][Full Text] [Related]
19. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
[TBL] [Abstract][Full Text] [Related]
20. Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.
Giurdanella G; Lupo G; Gennuso F; Conti F; Furno DL; Mannino G; Anfuso CD; Drago F; Salomone S; Bucolo C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
